Literature DB >> 15080037

Treatment of physiological and pathological neonatal jaundice.

Stevie Boyd1.   

Abstract

Neonatal jaundice (hyperbilirubinaemia) is a common condition and usually a benign transitional event that resolves without treatment. However, in some infants it can be a symptom of an underlying pathological condition, which is important to identify. If bilirubin levels necessitate it, treatment for jaundice involves phototherapy and/or exchange transfusion of donor blood. In cases of pathological jaundice the underlying cause must also be treated. Parental involvement is important to minimise the trauma of having a sick baby and its effect on bonding.

Entities:  

Mesh:

Year:  2004        PMID: 15080037

Source DB:  PubMed          Journal:  Nurs Times        ISSN: 0954-7762


  3 in total

1.  Clinical Implications of Bilirubin-Associated Neuroprotection and Neurotoxicity.

Authors:  Nicholas V Mendez; Jeffrey A Wharton; Jenna L Leclerc; Spiros L Blackburn; Martha V Douglas-Escobar; Michael D Weiss; Christoph N Seubert; Sylvain Doré
Journal:  Int J Clin Anesthesiol       Date:  2013-09-29

Review 2.  Hyperbilirubinemia in Neonates: Types, Causes, Clinical Examinations, Preventive Measures and Treatments: A Narrative Review Article.

Authors:  Sana Ullah; Khaista Rahman; Mehdi Hedayati
Journal:  Iran J Public Health       Date:  2016-05       Impact factor: 1.429

3.  Neonatal Hyperbilirubinemia treatment by Locally Made Low-Cost Phototherapy Units.

Authors:  Netsanet Workneh Gidi; Matthias Siebeck
Journal:  Ethiop J Health Sci       Date:  2021-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.